✦ LIBER ✦

A metabolic network approach for the identification and prioritization of antimicrobial drug targets

✍ Scribed by Arvind K. Chavali; Kevin M. D’Auria; Erik L. Hewlett; Richard D. Pearson; Jason A. Papin

Book ID: 116917639
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 608 KB
Volume: 20
Category: Article
ISSN: 0966-842X
DOI: 10.1016/j.tim.2011.12.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Network-Based Tools for the Identificati

Network-Based Tools for the Identification of Novel Drug Targets

✍ Farkas, I. J.; Korcsmaros, T.; Kovacs, I. A.; Mihalik, A.; Palotai, R.; Simko, G 📂 Article 📅 2011 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 331 KB

Metabolite-centric approach using genome

Metabolite-centric approach using genome-scale metabolic network for drug targeting of pathogens

✍ S.Y. Lee; H.U. Kim; T.Y. Kim 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 65 KB

The mode-of-action by network identifica

The mode-of-action by network identification (MNI) algorithm: a network biology approach for molecular target identification

✍ Xing, Heming; Gardner, Timothy S 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 182 KB

Mycoplasma genitalium: A comparative gen

Mycoplasma genitalium: A comparative genomics study of metabolic pathways for the identification of drug and vaccine targets

✍ Azeem Mehmood Butt; Shifa Tahir; Izza Nasrullah; Muhammad Idrees; Jun Lu; Yigang 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 373 KB

Key animal models for the identification

Key animal models for the identification and validation of drug targets

✍ Patrick Nef 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Model Organisms in Drug Discovery || Dro

Model Organisms in Drug Discovery || Drosophilaâ a Model System for Targets and Lead Identification in Cancer and Metabolic Disorders

✍ Carroll, Pamela M.; Fitzgerald, Kevin 📂 Article 📅 2003 🏛 John Wiley & Sons, Ltd 🌐 English ⚖ 595 KB

Genetic and genomic research in model organisms has tremendously accelerated our understanding of the basic biological processes that lie at the heart of human disease. The genetic dissection of disease-relevant signaling pathways in Drosophila offers an ideal tool to identify novel drug targets for